Protocols
1 protocol(s) meet the specified criteria
Drug: G1T48
Protocol No.TitleStatus
G1T48-01A Phase 1, Open-Label, Multicenter Study to Assess the Safety, Tolerability, Pharmacokinetics, and Preliminary Antitumor Activity of Ascending Doses of G1T48 in Women with Estrogen Receptor-Positive, HER2-Negative Advanced Breast Cancer Open